Halozyme Therapeutics, Inc. (HALO)
108.64
+0.47
(+0.43%)
USD |
NASDAQ |
Aug 24, 16:00
108.64
0.00 (0.00%)
After-Hours: 19:20
Halozyme Therapeutics 1 Year Total Returns (Daily) : 51.05% for Aug. 21, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 21, 2026 | 51.05% |
| August 20, 2026 | 49.19% |
| August 19, 2026 | 53.79% |
| August 18, 2026 | 52.10% |
| August 17, 2026 | 53.11% |
| August 14, 2026 | 50.53% |
| August 13, 2026 | 54.57% |
| August 12, 2026 | 58.95% |
| August 11, 2026 | 63.17% |
| August 10, 2026 | 63.15% |
| August 07, 2026 | 66.05% |
| August 06, 2026 | 37.61% |
| August 05, 2026 | 37.46% |
| August 04, 2026 | 38.74% |
| August 03, 2026 | 39.39% |
| July 31, 2026 | 37.64% |
| July 30, 2026 | 38.65% |
| July 29, 2026 | 41.03% |
| July 28, 2026 | 44.54% |
| July 27, 2026 | 39.90% |
| July 24, 2026 | 39.41% |
| July 23, 2026 | 38.05% |
| July 22, 2026 | 35.24% |
| July 21, 2026 | 40.56% |
| July 20, 2026 | 36.56% |
| Date | Value |
|---|---|
| July 17, 2026 | 34.61% |
| July 16, 2026 | 33.67% |
| July 15, 2026 | 33.96% |
| July 14, 2026 | 30.18% |
| July 13, 2026 | 33.18% |
| July 10, 2026 | 32.22% |
| July 09, 2026 | 38.95% |
| July 08, 2026 | 44.03% |
| July 07, 2026 | 50.44% |
| July 06, 2026 | 49.59% |
| July 02, 2026 | 47.57% |
| July 01, 2026 | 45.52% |
| June 30, 2026 | 50.46% |
| June 29, 2026 | 47.83% |
| June 26, 2026 | 42.70% |
| June 25, 2026 | 38.83% |
| June 24, 2026 | 32.00% |
| June 23, 2026 | 31.86% |
| June 22, 2026 | 30.64% |
| June 18, 2026 | 28.97% |
| June 17, 2026 | 29.11% |
| June 16, 2026 | 29.15% |
| June 15, 2026 | 32.05% |
| June 12, 2026 | 27.43% |
| June 11, 2026 | 31.35% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Incyte Corp. | 47.71% |
| Neurocrine Biosciences, Inc. | 12.78% |
| AVITA Medical, Inc. | 111.8% |
| Agenus, Inc. | 77.02% |
| Amgen, Inc. | 53.88% |